Bluefish Pharmaceuticals AB (publ) is a pharmaceutical company based in Stockholm, Sweden. Established in 2005, the company focuses on the development and commercialization of generic pharmaceuticals. Bluefish aims to provide high-quality, affordable medications to improve patient access to essential treatments. The company operates primarily in the European market and has a portfolio that includes a variety of therapeutic areas.
The company emphasizes its commitment to quality and regulatory compliance, ensuring that its products meet the necessary standards set by health authorities. Bluefish Pharmaceuticals engages in research and development to expand its product offerings and enhance its market presence. Through strategic partnerships and collaborations, the company seeks to leverage its capabilities in the pharmaceutical sector.